Group 1 - The Chinese medicine sector increased by 1.67% on January 5, with Weikang Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] - Notable individual stock performances include Weikang Pharmaceutical with a closing price of 28.46, up 11.56%, and Zhongsheng Pharmaceutical at 20.88, up 10.01% [1] Group 2 - The net inflow of main funds in the Chinese medicine sector was 511 million yuan, while retail funds saw a net outflow of 219 million yuan [2] - The top stock by main fund inflow was Zhongsheng Pharmaceutical with 253 million yuan, representing 15.19% of its total [3] - The overall trading volume for Zhongsheng Pharmaceutical was 827,200 shares, with a total transaction value of 1.665 billion yuan [1][3]
中药板块1月5日涨1.67%,维康药业领涨,主力资金净流入5.11亿元